Inhibition of interleukin-1β converting enzyme by N-acyl-aspartyl aryloxymethyl ketones
- 1 July 1995
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 5 (13) , 1409-1414
- https://doi.org/10.1016/0960-894x(95)00232-i
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shockCell, 1995
- The synthesis and evaluation of peptidyl aspartyl aldehydes as inhibitors of ice.Bioorganic & Medicinal Chemistry Letters, 1994
- P1 Aspartate-Based Peptide .alpha.-((2,6-Dichlorobenzoyl)oxy)methyl Ketones as Potent Time-Dependent Inhibitors of Interleukin-1.beta.-Converting EnzymeJournal of Medicinal Chemistry, 1994
- Prevention of Vertebrate Neuronal Death by the crmA GeneScience, 1994
- Phenylalkyl ketones as potent reversible inhibitors of interleukin-1β converting enzymeBioorganic & Medicinal Chemistry Letters, 1993
- Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3Cell, 1993
- The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzymeCell, 1993
- Synthesis of a potent, reversible inhibitor of interleukin-1β converting enzymeBioorganic & Medicinal Chemistry Letters, 1992
- Molecular Cloning of the Interleukin-1β Converting EnzymeScience, 1992
- A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytesNature, 1992